Nearly a year ago, Dr. Fauci touted ZYESAMI as a promising treatment for COVID-19. However, the drug appears no closer to receiving FDA approval. Meanwhile, treatments including remdesivir, Molnupiravir, Paxlovid and the COVID-19 vaccines were fast tracked to approval.
The members are seeking an explanation for the delayed review process and favoritism shown by federal health agencies for large drug manufacturers.